Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses
2006

Impact of HPV Vaccination on Cervical Cancer in Finland

publication 10 minutes Evidence: high

Author Information

Author(s): Barnabas Ruanne V, Laukkanen Päivi, Koskela Pentti, Kontula Osmo, Lehtinen Matti, Garnett Geoff P

Primary Institution: Cancer Epidemiology Unit, University of Oxford

Hypothesis

How will HPV vaccination affect cervical cancer rates in Finland?

Conclusion

HPV vaccination has the potential to significantly decrease HPV type-specific cervical cancer incidence.

Supporting Evidence

  • HPV vaccines have shown 90%-100% efficacy in preventing HPV infection in trials.
  • Vaccinating 90% of young women before sexual debut could decrease cervical cancer incidence by 91%.
  • Changes in sexual behavior and smoking contributed to increased cervical cancer rates among Finnish women.

Takeaway

Vaccinating young women against HPV can help prevent cervical cancer. If many women get vaccinated before they start having sex, it can reduce cancer cases a lot.

Methodology

A mathematical model was developed to estimate HPV transmission and cervical cancer incidence based on Finnish data.

Potential Biases

Potential biases in self-reported sexual behavior and underreporting of sensitive data.

Limitations

The model relies on assumptions about sexual behavior and vaccine efficacy, which may not fully capture real-world complexities.

Participant Demographics

The study focused on Finnish women, particularly those aged 30-39.

Statistical Information

P-Value

0.6

Confidence Interval

95% CI, 90%-100%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030138

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication